pMDI Formulation Development

Formulations for pMDIs can be developed using tradition or “quality by design” approaches and cover the selection of physical form, micronisation, a full materials characterisation package (the extent of which we will agree with you first), formulation development and in vitro testing.  Control  of suspension (or solution) properties with suitable materials selection and excipients will allow for optimised performance.

Following preliminary stability testing we will then make GMP supplies for your clinical trials, with no need for technology transfer to a different partner.

The process will be carried out by the very staff who were involved in the formulation development and under the same management team.

Pharmaterials have a highly experienced team and an outstanding infrastructure of characterisation and processing equipment.

To discuss our comprehensive formulation development for pMDIs please contact us.